Fuad El-Hibri, Chairman at Emergent BioSolutions Inc. (EBS), sold 38,070 shares at $98.85 ($3.8M) on 2020-09-24, disclosed to the SEC on 2020-09-25.
Open-market sale of $3.8M EBS by Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.58 | 13,000 | $1.3M | 34.5% |
| 2 | $98.85 | 12,535 | $1.2M | 32.7% |
| 3 | $98.85 | 12,535 | $1.2M | 32.7% |
| Total | $99.44 avg | 38,070 | $3.8M | 100% |
| Filing → |
| EBS | SELL | 2020-09-18 | $6.1M | — | Filing → |
| EBS | SELL | 2020-09-11 | $4.1M | — | Filing → |
| EBS | SELL | 2020-05-01 | $3.0M | — | Filing → |